To see more information:

Andrus Tasa

Corporate finance and assets
The average monthly turnover of companies is EUR, profit margin 0%, forecast turnover in 2024 . Real estate as of...

Turnover prognosis 2024

7,870,508 €

Increased
by 43 % compared to the last year

Total average monthly turnover

702,872 €

Available credit: 121,900 €

Gross profits 2024

10,097,785 €

Retained profits:
10,056,889 € (100 %)
Net profits:
40,896 € (0 %)

Balance sheet total 2024

11,650,903 €

Profit margin 2024

0 %
100 %

1%

1 € assets to cover short-term liabilities

7,67 €

The main activity of TBD Pharmatech is fine chemistry and synthesis services and small-scale production of active pharmaceutical ingredients. The company's main customers are chemical, pharmaceutical and biotechnology

Loader

App Ad

Scorestorybook Chrome extension

The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.